TipRanks (Sat, 14-Mar 2:00 AM ET)
TipRanks (Fri, 13-Mar 9:20 AM ET)
Top Brass Cashes Out: Rapid Micro Biosystems Leaders Quietly Unload Shares
TipRanks (Thu, 12-Mar 10:04 PM ET)
Rapid Micro Biosystems Earnings Call Balances Growth, Pressure
TipRanks (Thu, 12-Mar 8:03 PM ET)
TipRanks (Thu, 12-Mar 12:40 PM ET)
Seeking Alpha News (Thu, 12-Mar 10:43 AM ET)
Rapid Micro Biosystems Posts Record 2025 Results, Guides Higher
TipRanks (Thu, 12-Mar 8:10 AM ET)
Rapid Micro Biosystems reports mixed Q4 results; introduces FY26 outlook
Seeking Alpha News (Thu, 12-Mar 7:15 AM ET)
Globe Newswire (Thu, 12-Mar 7:00 AM ET)
Globe Newswire (Thu, 12-Mar 6:30 AM ET)
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
Rapid Micro Biosystems - Class A trades on the NASDAQ stock market under the symbol RPID.
As of March 13, 2026, RPID stock price declined to $2.83 with 816,493 million shares trading.
RPID has a beta of 1.53, meaning it tends to be more sensitive to market movements. RPID has a correlation of 0.08 to the broad based SPY ETF.
RPID has a market cap of $125.43 million. This is considered a Micro Cap stock.
Last quarter Rapid Micro Biosystems - Class A reported $11 million in Revenue and -$.28 earnings per share. This beat revenue expectation by $348,670 and missed earnings estimates by -$.05.
In the last 3 years, RPID traded as high as $4.94 and as low as $.58.
The top ETF exchange traded funds that RPID belongs to (by Net Assets): VTI, VXF, IWC, AVSC, DFAT.
RPID has outperformed the market in the last year with a return of +24.1%, while the SPY ETF gained +21.4%. However, in the most recent history, RPID shares have underperformed the stock market with its stock returning -22.3% in the last 3 month period and -34.6% for the last 2 week period, while SPY has returned -2.6% and -3.5%, respectively.
RPID support price is $3.24 and resistance is $3.61 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RPID shares will trade within this expected range on the day.